Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT06242691 |
Title | Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Merck Sharp & Dohme LLC |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
South Texas Accelerated Research Therapeutics (START) ( Site 0005) | RECRUITING | San Antonio | Texas | 78229 | United States | Details |
The Alfred Hospital ( Site 0103) | RECRUITING | Melbourne | Victoria | 3004 | Australia | Details |
Rambam Health Care Campus-Oncology Division ( Site 0602) | RECRUITING | Haifa | 3109601 | Israel | Details | |
Hadassah Medical Center ( Site 0604) | RECRUITING | Jerusalem | 9112001 | Israel | Details | |
Sheba Medical Center ( Site 0605) | RECRUITING | Ramat Gan | 5265601 | Israel | Details | |
Sourasky Medical Center ( Site 0601) | RECRUITING | Tel Aviv | 6423906 | Israel | Details |